Title : ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine.

Pub. Date : 2015

PMID : 26557761






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens
2 BACKGROUND: We aimed to investigate the impact of RRM1 and ERCC1 expression on response to cisplatin and/or gemcitabine chemotherapy in patients with lung, ovarian or pancreatic cancer. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens